ClinicalTrials.gov
ClinicalTrials.gov Menu

Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01298752
Recruitment Status : Terminated (Recruiting or enrolling participants has halted prematurely and will not resume; participants are no longer being examined or treated.)
First Posted : February 18, 2011
Last Update Posted : December 17, 2013
Sponsor:
Information provided by (Responsible Party):
Bausch & Lomb Incorporated

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : September 2011
  Actual Study Completion Date : November 2011
  Certification/Extension First Submitted : February 13, 2013